Neurology
Conference Coverage
Gene-replacement therapy shows promise in X-linked myotubular myopathy
An investigational gene therapy decreases ventilator dependence and may improve motor development in children with a rare, life-threatening...
Feature
COVID-19 diagnosed on CTA scan in stroke patients
Conference Coverage
ODC1 gene linked to newly described neurodevelopmental disorder
A previously undescribed neurometabolic disease has been linked to a gain-of-function mutation of the ODC1 gene.
Conference Coverage
Ataluren delays disease milestones in patients with nonsense mutation DMD
Patients who received ataluren in addition to standard of care were 2.2 years older when they lost ambulation, compared with patients receiving...
Conference Coverage
Newer DMTs are more effective than injectable DMTs in pediatric MS
A retrospective study suggests that the safety and tolerability of newer disease-modifying therapies are the same in children as in adults.
Conference Coverage
Study supports halting antiseizure medications after neonatal seizures
A registry study found that halting antiseizure medications after acute symptomatic neonatal seizures had similar outcomes to maintenance therapy...
Conference Coverage
Evaluating the impact of new pediatric brain tumor classifications
Additional molecular subtypes of childhood brain tumors will have far-reaching implications for diagnosis and management.
Conference Coverage
Acute flaccid myelitis: More likely missed than diagnosed
A retrospective series reports that 78% of children with acute flaccid myelitis are misdiagnosed initially, causing delays in treatment.
Conference Coverage
Cerebral blood flow may predict children’s recovery from persistent postconcussion symptoms
Higher cerebral blood flow at 4-6 weeks post injury is associated with poor recovery at 10 weeks among children with concussion.
Conference Coverage
Nusinersen provides continued benefits to presymptomatic children with SMA
Most children developed normally in an interim analysis of the NURTURE trial that did not find any new safety concerns.
Conference Coverage
CBD for LGS: Fewer seizures, but thrombocytopenia risk
Cannabidiol reduces seizures in Lennox Gastaut syndrome out to 3 years, but has been linked to thrombocytopenia in children also on valproic acid...